Reference health
FCGR2A and FCGR3A Polymorphisms Associated With Clinical Outcome of Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Cancer Patients Treated With Single-Agent Cetuximab
28/28 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 28 checked references that resolve
resolves10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M
Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma
resolves10.1056/NEJMoa033025
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
resolves10.1200/JCO.2004.10.182
Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor
resolves10.1002/cncr.10372
Monoclonal antibodies to target epidermal growth factor receptor–positive tumors
resolves10.1007/s002620050475
Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck
resolves10.1038/sj.bjc.6602930
Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?
resolves10.1182/blood-2002-02-0469
In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas
resolves10.1182/blood.V99.3.754
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
resolves10.1074/jbc.M009483200
High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR
resolves10.1172/JCI119616
A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.
resolves10.1200/JCO.2003.05.013
Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma
resolves10.1200/JCO.2006.06.7595
Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines
resolves10.1016/S0022-1759(96)00164-0
Rapid detection of the ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED)
resolves10.1016/S0022-1759(00)00240-4
A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotyping
resolves10.1002/sim.4780100510
A comparison of two simple hazard ratio estimators based on the logrank test
resolves10.1016/S1470-2045(05)70102-9
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
resolves10.1158/0008-5472.CAN-06-0191
<i>KRAS</i> Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
resolves10.1097/01.fpc.0000220562.67595.a5
Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab
resolves10.1002/1521-4141(2001010)31:10<3016::AID-IMMU3016>3.0.CO;2-J
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 /neu-positive breast cancer cells
resolves10.1042/bst0250705
Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma
resolves10.4049/jimmunol.147.4.1338
A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding
resolves10.1172/JCI116022
On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.
resolves10.1182/blood-2004-02-0651
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia
resolves10.1200/JCO.2005.04.6011
<i>FCGR2A</i>Polymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor
resolves10.1182/blood-2003-07-2548
FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia
The 4 references without a DOI — listed, not checked
no DOI — not checkedFan Z, Masui H, Altas I, et al: Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 53:4322,1993-4328,
no DOI — not checkedArteaga CL: The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 19:32s,2001-40s,
no DOI — not checkedHollander M, Wolfe DA: Nonparametric Statistical Methods . New York, NY, Wiley & Sons, 1973
no DOI — not checkedPirie W: Jonckheere Tests for Ordered Alternatives, in Kotz S, Johnson NL, Read CB (eds): Encyclopedia of Statistical Sciences , New York, NY, Wiley & Sons (vol 4), pp 315,1983-318
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1200/jco.2006.08.8021"><img src="https://citestamp.com/citestamped/10.1200/jco.2006.08.8021/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1200/jco.2006.08.8021)